Skip to main content

Posts

Showing posts with the label clinical trials

The Ghost Writers of the Pharmaceutical Industry

There is a huge difference between finding out that your favourite author uses a ghostwriter to write their novels and finding out that the pharmaceutical industry uses ghostwriters for the majority of their scientific content. Who are the medical ghostwriters? These writers aren’t called ghostwriters; they have a more professional name: medical writers. They are anyone with a science background (which doesn’t have to be a background in the therapy areas the agency is working on) and most likely a PhD.  Medical writers work in agencies and these agencies are employed by pharmaceutical companies to help them with the approval and the promotion of new therapies coming to the drug market by providing advice and the preparation of various scientific materials such as slide decks and publications for scientific journals. This is where the problem arises, a medical writer can write publications but will not have their name published on it, and instead, the name of the

Does the public trust clinical trials?

Whilst you're reading this, hundreds of clinical studies are taking place to find the latest breakthrough drug in diabetes, heart, immunological or rare diseases that only affect a handful of people but are debilitating. The results of these trials are being published monthly in medical journals, most with positive results; but to what degree can a member of the public trust the results of clinical trials; particularly those sponsored by big pharmaceutical companies? How much does the public trust clinical trials? With the amount of work that is being done recently,   public trust in clinical trials has been improving although not to the needed extent. In 2013, a public survey conducted by the Health Research Authority (HRA) for the NHS, respondents had less confidence in health research studies undertaken by the pharmaceutical industry. In this survey, there were 1,295 adults aged 18 years or more from across England in 2013. Only 27% of participants in t